These studies indicated that mammalian glucagon is derived from a 179-180 amino acid precursor (the human protein has one less amino acid at its carboxyl terminus than the hamster protein). The precursor, in addition, contains the sequences of two polypeptides of 37 and 35 amino acids that are bound by a pair of basic amino acids. The two polypeptides are related to glucagon and are designated glucagon-like peptides (GLP) 1 and 2, respectively. Although GLP-1 and -2 have not been previously isolated from the pancreas or other tissues, their homology with glucagon and other members of the glucagon-secretion family suggests that they have unique, although presently undetermined, physiologic properties. It is suggested that a series of duplications of the coding regions or exons and subsequent mutation produced glucagon and the two glucagonlike peptides. The assignment of the preproglucagon gene to a human chromosome would be important in determining its relationship and close linkage to other genetic markers.
A complementary DNA encoding Syrian hamster preproglucagon messenger RNA as well as the human gene was isolated and characterized. 1 These studies indicated that mammalian glucagon is derived from a 179-180 amino acid precursor (the human protein has one less amino acid at its carboxyl terminus than the hamster protein). The precursor, in addition, contains the sequences of two polypeptides of 37 and 35 amino acids that are bound by a pair of basic amino acids. The two polypeptides are related to glucagon and are designated glucagon-like peptides (GLP) 1 and 2, respectively. Although GLP-1 and -2 have not been previously isolated from the pancreas or other tissues, their homology with glucagon and other members of the glucagon-secretion family suggests that they have unique, although presently undetermined, physiologic properties. It is suggested that a series of duplications of the coding regions or exons and subsequent mutation produced glucagon and the two glucagonlike peptides. The assignment of the preproglucagon gene to a human chromosome would be important in determining its relationship and close linkage to other genetic markers.
Since the physiologic effects of glucagon play an important role in diabetes, such genetic information may eventually lead to a better understanding of the regulation of this hormone during the hyperglycemia associated with this disease.
Somatic cell hybrids formed between cultured human and mouse cells were used to map the human gene coding for preproglucagon.
2 ' 4 These hybrids contain mouse chromosomes but retain only a partial and random complement of human chromosomes. DNA from a panel of human-mouse somatic cell hybrids whose human chromosome composition was known was analyzed for the presence or absence of the human preproglucagon gene by hybridization with a cloned segment of the human gene. This study indicated that the human preproglucagon gene (designated GCG) is on chromosome 2.
MATERIALS AND METHODS
Cell hybrids. The somatic cell hybrids were constructed and maintained as previously described.
25 - 10 Clones were selected and analyzed for characteristic human enzyme markers whose genes had been assigned to a particular chromosome. 211 In addition, on the same passage the human chromosomes were identified by Giemsa-trypsin staining 8 and DNA was isolated for use in filter hybridization.
12
Identification of the human glucagon gene. Five micrograms of DNA from each cell line was digested to completion with the restriction endonuclease EcoRI. The resulting DNA fragments were separated by electrophoresis in a 0.8% agarose gel and then transferred to a nitrocellulose filter (see ref. 13 ). The filters were hybridized as described previously 14 with a 32 P-labeled 2134 base pair EcoRI fragment from \hglucagon1, 1 which contained a region, exon 2, coding for preproglucagon 11-65 and part of another exon corresponding to preproglucagon 66-99, as well as flanking intervening sequences or introns. This probe hybridized to a 2.0-kilobase pair (kb) human EcoRI fragment, as expected, and to a 7.8-kb mouse EcoRI fragment. 
RESULTS
Chromosomal mapping of the glucagon gene. The human gene was mapped by correlating the presence of specific human chromosomes in human-mouse somatic cell hybrids with the human glucagon gene sequences in the hybrid DNA. The human chromosomes in these hybrid cells were identified through a combination of karyotyping, Giemsatrypsin banding, and analysis of human specific gene markers. 28 " The human glucagon gene was found to be present or absent as determined by hybridization with phg 14-4 together with human chromosome 2 and human IDH1 (isocitrate dehydrogenase, soluble), the enzyme marker for human chromosome 2, in an analysis of 26 hybrids (Table 1) . No other chromosomes or chromosome-specific isozyme markers cosegregated with GCG. Examples of human glucagon {GCG) gene positive and negative cell hybrid DNAs are shown in Figure 1 . The phg 14-4 glucagon probe hybridized to both mouse and human DNAs yielding bands of -7.8 kb ( Figure 1A, lanes 2 and 3) and ~2.0 kb ( Figure 1A,  lanes 1 and 4) , respectively. The human-mouse hybrid cell DNA ( Figure 1B, lanes 1, 2, 4, 6, 8, 9 , and 10) is positive for the glucagon gene and for human chromosome 2. They contain a single human band at 2.0 kb. Lanes 3, 5, 7, and 11 show hybrid DNAs that are negative for both the glucagon gene and human chromosome 2. They contain only the mouse band found in all the hybrid cell DNAs. Thus, the human glucagon gene, GCG, is located on chromosome 2.
DISCUSSION
Preproglucagon is synthesized in the pancreas, intestine, and possibly the brain; tissue-specific posttranslational processing generates different peptides in the pancreas and intestine. 1 Although the physiologic properties of glucagon have been extensively studied and its role in the maintenance of normal glucose levels is well established, the physiologic functions of the larger glucagon-containing peptides found in the intestine or glucagon-like peptides, GLP-1 and -2, whose presence is predicted from the sequence of preproglucagon, remain to be determined. Understanding the function of the other peptides derived from preproglucagon may indicate their role, if any, in human disease. There has been only one published case of congenital isolated glucagon deficiency 15 since, unlike insulin deficiency, the absence of glucagon is lethal. However, recent evidence 1617 indicates that in diabetes it is the hyperglycemia resulting from hyperglucagonemia that is the most damaging aspect of the disease. The elucidation of the structure of preproglucagon and its gene, and now the assignment of the gene to human chromosome 2, will facilitate physiologic and ge-HUMAN GLUCAGON GENE IS LOCATED ON CHROMOSOME 2 A. netic studies of the role of this important hormone in normal and disease states.
